Glyclopyramide
Jump to navigation
Jump to search
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C11H14ClN3O3S |
Molar mass | 303.76 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.
It is classified as second generation.[1]
References
External links
Categories:
- CS1 Japanese-language sources (ja)
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- Articles with changed CASNo identifier
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Drugboxes which contain changes to verified fields
- Potassium channel blockers
- Benzenesulfonylureas
- 1-Pyrrolidinyl compounds
- Chloroarenes
- All stub articles
- Gastrointestinal system drug stubs